ALCON LABORATORIES INC 300VS Accurus Phacoemulsifier

( Brand: Alcon Laboratories Inc ), ( Model: ACCURUS 300VS ), ( Serial Number: 0201450701x ), ( Manufacturer Part Number: 300VS )

Review ALCON LABORATORIES INC Accurus Phacoemulsifier

The Alcon Laboratories 300VS Accurus Phacoemulsifier is a state-of-the-art surgical instrument designed for use in cataract surgery. This device is engineered to provide surgeons with exceptional control, precision, and efficiency, resulting in improved patient outcomes.

The Alcon Accurus Phacoemulsifier features the company's proprietary "Accurus" technology, which utilizes a unique, vibrating ultrasonic tip to effectively break up and remove cataracts. This tip, coupled with the system's advanced fluidics, allows for smooth and precise emulsification, reducing the risk of complications and improving surgical efficiency.

The 300VS model offers several enhancements over previous versions, including an improved ergonomic design for greater comfort during long surgeries. The system also features a high-resolution, 3D HD display that provides surgeons with real-time, high-definition images of the surgical site. This allows for enhanced visualization and increased accuracy during the procedure.

The Alcon Accurus Phacoemulsifier 300VS is designed to be user-friendly, with a straightforward and intuitive interface. It is also easily customizable, allowing surgeons to tailor the settings to their individual preferences and the specific needs of each patient.

In addition to its surgical capabilities, the Alcon Accurus Phacoemulsifier 300VS is also designed with patient comfort in mind. The system features a quiet operation, reducing the overall noise level in the operating room. It also includes advanced temperature control to maintain the optimal temperature of the surgical fluid, ensuring patient comfort during the procedure.

Overall, the Alcon Laboratories 300VS Accurus Phacoemulsifier is a powerful and versatile tool for cataract surgery. Its advanced technology, user-friendly design, and focus on patient comfort make it an excellent choice for surgeons looking to improve their surgical efficiency and patient outcomes.

Alcon Laboratories 300 and Accurus Phacoemulsifiers are two popular choices for cataract surgery systems. Both have their strengths and weaknesses.

1. Stability: The Alcon Laboratories 300 is known for its stability and smooth operation, which can reduce surgeon fatigue during long procedures.

2. Customization: It offers a wide range of tip and handpiece options, allowing surgeons to customize the system to their specific needs and preferences.

3. Cost-effective: The Alcon Laboratories 300 is generally considered to be a more cost-effective option compared to some other high-end phacoemulsifiers.

1. Lack of some advanced features: The Alcon Laboratories 300 may not have some of the more advanced features found in newer phacoemulsifiers, such as real-time ultrasound imaging.

2. Requires more manual input: Compared to some more automated systems, the Alcon Laboratories 300 requires more manual input from the surgeon.

1. Advanced features: The Accurus Phacoemulsifier offers advanced features such as real-time ultrasound imaging, which can help surgeons more precisely target the cataract and minimize damage to surrounding tissues.

2. Automation: The Accurus Phacoemulsifier is known for its high level of automation, which can reduce surgeon fatigue and improve precision.

1. Higher cost: The Accurus Phacoemulsifier is generally more expensive than the Alcon Laboratories 300.

2. Limited customization: While the Accurus Phacoemulsifier offers a range of tip and handpiece options, it may not offer as much customization as the Alcon Laboratories 300.

Both the Alcon Laboratories 300 and Accurus Phacoemulsifier are high-quality phacoemulsifiers with their own strengths and weaknesses. The choice between the two ultimately depends on the surgeon's specific needs and preferences, as well as budget considerations. If cost-effectiveness and customization are key priorities, the Alcon Laboratories 300 may be the better choice. If advanced features and automation are more important, the Accurus Phacoemulsifier may be the better choice.

I would recommend scheduling a demo of both systems to see which one fits your specific needs and preferences the best. It's important to consider factors such as cost, ease of use, and advanced features when making a decision. Ultimately, the goal is to choose a phacoemulsifier that will help you deliver the best possible outcomes for your patients.

Details:

Reline will attempt to replace product prior issuing credit. 1755 Enterprise Parkway Suite 4 Twins burg, OH 44087, The and photos represent best efforts to convey information our opinions about a product. Shipping cost is calculated by zip code and available at the top of page. Current rates are $175 for packing and pelleting each standard pallet Standard size is 48 x40 x60 $300 non-standard.

$350 for packing and pelleting each custom reinforced pallet.

part #: 300vs prices

• $161.49-$600.00

specifications quakedental:

• brand: Alcon Laboratories Inc
• model#: ACCURUS 300VS
• serial number: 0201450701x
• manufacturer part number: 300VS

general quakedental:

• condition: Used
• Business Industrial > Healthcare, Lab Dental > Other Healthcare, Lab Dental

returns quakedental:

• policy: Returns Accepted
• method: Money back
• paid by: Seller
• time: 30 Days

shipping quakedental:

• class: Freight
• service: Flat Rate Freight
• cost: $953.00
• type: Fixed

payments quakedental:

• credit card: Visa
• wallet: Paypal
• other

offer quakedental:

• best offers: True
• availability: In Stock
• started: September 19, 2024
• options: Ship-to-home
• sold: 0
• quantity: 1

seller quakedental:

• # reviews: 11936
• city: Atlanta, Georgia
• rating: 99.5%

Alcon Laboratories Inc 300VS Is Similar To:

• Medtronic 8065740240 Alcon Accurus Legacy Footswitch (35.8% similar) It would be highly recommended and wise to have a bio-med completely check the product for its performance safety parameters before actual use patient care and/or diagnosis...(October 16th, 2025)